PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026BMC Pulmonary Medicine0 citationsOpen Access

Global prevalence of dyspnoea: a systematic review and meta-analysis

View Full Paper
MMMaitri MunsifThe University of MelbourneYJYuxin JiaoAustin HealthSKSu‐Wei KhungAustin Health

Key Points

  • This review aims to synthesize the global prevalence of dyspnoea across different income countries and identify associated factors.
  • Systematic review and meta-analysis of studies evaluating dyspnoea prevalence and factors like age, BMI, and lung function.
  • Screened 13,504 records and included 56 studies with 450,520 participants based on PRISMA guidelines.
  • Calculated pooled prevalence using the mMRC Dyspnoea Scale.
  • Pooled prevalence of dyspnoea was 22.2% [95% CI 17.5–27.2], with 6.1% reporting moderate (mMRC 2) and 1.2% reporting severe dyspnoea (mMRC 4).
  • Higher prevalence in women (6.7%) compared to men (4.3%).
  • Geographical variation noted, with higher prevalence in North America (29.4%) compared to Australia/New Zealand (19.6%).

Abstract

Dyspnoea is a common subjective experience associated with decreased exercise tolerance and mortality. Although several studies have explored its prevalence in the general population, there has been limited synthesis over broad income settings, particularly low-income countries. This review and meta-analysis aims to address these gaps by reviewing the global prevalence of dyspnoea across low, middle, and high-income countries and associated factors. A systematic review and meta-analysis were completed evaluating the prevalence of dyspnoea in the general population and associated factors including age, BMI, smoking status, underlying conditions, lung function indices and country of residence. The protocol followed PRISMA guidelines and was prospectively registered with PROSPERO (CRD42022374929). Of 13,504 records screened, 56 studies were included with a total of 450,520 participants. Using the mMRC Dyspnoea Scale, (n = 43), the pooled prevalence of dyspnoea was 22.2% 95% CI 17.5–27.2. 6.1% 95% CI 4.3–8.2 reported moderate dyspnoea (mMRC 2), 2.5% 95% CI 1.5–3.6 described moderate-severe dyspnoea (mMRC 3), and 1.2% 95% CI 0.7–1.9 reported severe dyspnoea (mMRC 4). Women reported more dyspnoea than men (6.7% vs. 4.3%). Rates of dyspnoea were higher in North America than in Australia/New Zealand (29.4% vs. 19.6%). No clear differences were noted between low-income countries and high-income countries, although data were limited. This review demonstrates a high burden of dyspnoea, affecting one in five adults in the general global population. Dyspnoea prevalence was higher in women and there was significant geographical variation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Munsif et al. (2026) studied this question.

synapsesocial.com/papers/6a0d4f62f03e14405aa9ab80https://doi.org/10.1186/s12890-026-04339-3
Ask AI
Helpful
Bookmark
Share
View Full Paper